Expanding easy-access HIV care for people with complex needs
Scaling Low-Barrier Care to Engage People with Complex Needs in HIV Treatment
['FUNDING_OTHER'] · UNIVERSITY OF WASHINGTON · NIH-11120872
The team will expand easy-access HIV clinics offering walk-in visits, incentives, and intensive support to help people with unstable housing, substance use, or mental health challenges stay on treatment and reach viral suppression.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11120872 on ClinicalTrials.gov |
What this research studies
You would be offered low-barrier care with walk-in medical visits, incentives for attending and achieving viral suppression, intensive help with housing, substance use, and mental health, and coordinated services across agencies. The project will open two new clinics in King County alongside the existing Max Clinic and use structured tools and the RE-AIM framework to track reach, adoption, implementation, and maintenance. Researchers will follow a population-based observational open cohort to see who uses the clinics and how viral suppression and care engagement change over time. They will also record how clinics adapt the program and which organizational strategies help the model spread to other areas.
Who could benefit from this research
Good fit: People living with HIV in King County who face unstable housing, active substance use, mental health disorders, or who have difficulty keeping regular clinic appointments would be ideal candidates.
Not a fit: People who already have stable HIV care with consistent viral suppression, or those living outside the Seattle/King County area, are unlikely to get direct benefit from this local expansion.
Why it matters
Potential benefit: If successful, this could make it much easier for people facing big life challenges to stay on HIV treatment and achieve durable viral suppression.
How similar studies have performed: Programs like the Max Clinic in Seattle have already shown substantial improvements in viral suppression, so this work builds on promising real-world results.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DOMBROWSKI, JULIA COOK — UNIVERSITY OF WASHINGTON
- Study coordinator: DOMBROWSKI, JULIA COOK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus